{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:39:46Z","timestamp":1776314386910,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Science and Health Joint Medical Research Project of Chongqing","award":["2024ZDXM004"],"award-info":[{"award-number":["2024ZDXM004"]}]},{"name":"The chongqing Natural Science Foundation Project","award":["CSTB2024NSCQ-MSX0616"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0616"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01869-w","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:51:35Z","timestamp":1754988695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multimodal fusion radiomic-immunologic scoring model: accurate identification of prostate cancer progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhonglin","family":"Zhang","sequence":"first","affiliation":[]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Xiling","family":"Gu","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Qiu","sequence":"additional","affiliation":[]},{"given":"Jiangqing","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Guangyong","family":"Ai","sequence":"additional","affiliation":[]},{"given":"Xiaojing","family":"He","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"2","key":"1869_CR1","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3390\/curroncol30020178","volume":"30","author":"CV Berenguer","year":"2023","unstructured":"Berenguer CV, Pereira F, C\u00e2mara JS, Pereira JAM. Underlying features of prostate Cancer-Statistics, risk factors, and emerging methods for its diagnosis. Curr Oncol. 2023;30(2):2300\u201321. https:\/\/doi.org\/10.3390\/curroncol30020178.","journal-title":"Curr Oncol"},{"issue":"3","key":"1869_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41416-022-02119-4","volume":"128","author":"K Brummel","year":"2023","unstructured":"Brummel K, Eerkens AL, de Bruyn M, Nijman HW. Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer. 2023;128(3):451\u20138. https:\/\/doi.org\/10.1038\/s41416-022-02119-4.","journal-title":"Br J Cancer"},{"issue":"11","key":"1869_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662\u201380. https:\/\/doi.org\/10.1038\/s41568-020-0285-7.","journal-title":"Nat Rev Cancer"},{"issue":"Pt B","key":"1869_CR4","doi-asserted-by":"publisher","first-page":"110981","DOI":"10.1016\/j.intimp.2023.110981","volume":"124","author":"JL Xu","year":"2023","unstructured":"Xu JL, Yang MX, Lan HR, Jin KT. Could immunoscore improve the prognostic and therapeutic management in patients with solid tumors? Int Immunopharmacol. 2023;124(Pt B):110981. https:\/\/doi.org\/10.1016\/j.intimp.2023.110981.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1869_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","volume":"26","author":"HK Angell","year":"2020","unstructured":"Angell HK, Bruni D, Barrett JC, Herbst R, Galon J. The immunoscore: colon cancer and beyond. Clin Cancer Res. 2020;26(2):332\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1851.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1869_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pros.24068","volume":"81","author":"Y Yang","year":"2021","unstructured":"Yang Y, Attwood K, Bshara W, et al. High intratumoral CD8\u2009+\u2009T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy. Prostate. 2021;81(1):20\u20138. https:\/\/doi.org\/10.1002\/pros.24068.","journal-title":"Prostate"},{"issue":"1","key":"1869_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12885-024-11929-z","volume":"24","author":"J Chen","year":"2024","unstructured":"Chen J, Yu F, He G, Hao W, Hu W. A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression. BMC Cancer. 2024;24(1):254. https:\/\/doi.org\/10.1186\/s12885-024-11929-z. Published 2024 Feb 23.","journal-title":"BMC Cancer"},{"issue":"1","key":"1869_CR8","doi-asserted-by":"publisher","first-page":"1841935","DOI":"10.1080\/2162402X.2020.1841935","volume":"9","author":"K Zhao","year":"2020","unstructured":"Zhao K, Li Z, Li Y, et al. Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis. Oncoimmunology. 2020;9(1):1841935. https:\/\/doi.org\/10.1080\/2162402X.2020.1841935.","journal-title":"Oncoimmunology"},{"key":"1869_CR9","doi-asserted-by":"publisher","first-page":"835630","DOI":"10.3389\/fimmu.2022.835630","volume":"13","author":"L He","year":"2022","unstructured":"He L, Huang Y, Chen X, et al. Development and validation of an Immune-Based prognostic risk score for patients with resected Non-Small cell lung cancer. Front Immunol. 2022;13:835630. https:\/\/doi.org\/10.3389\/fimmu.2022.835630.","journal-title":"Front Immunol"},{"key":"1869_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","volume":"88","author":"X He","year":"2023","unstructured":"He X, Liu X, Zuo F, Shi H, Jing J. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol. 2023;88:187\u2013200. https:\/\/doi.org\/10.1016\/j.semcancer.2022.12.009.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1869_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13048-023-01248-5","volume":"16","author":"R Gu","year":"2023","unstructured":"Gu R, Tan S, Xu Y, et al. CT radiomics prediction of CXCL9 expression and survival in ovarian cancer. J Ovarian Res. 2023;16(1):180. https:\/\/doi.org\/10.1186\/s13048-023-01248-5.","journal-title":"J Ovarian Res"},{"issue":"4","key":"1869_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/hed.27299","volume":"45","author":"C Mossinelli","year":"2023","unstructured":"Mossinelli C, Tagliabue M, Ruju F, et al. The role of radiomics in tongue cancer: A new tool for prognosis prediction. Head Neck. 2023;45(4):849\u201361. https:\/\/doi.org\/10.1002\/hed.27299.","journal-title":"Head Neck"},{"issue":"2","key":"1869_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00330-022-09109-3","volume":"33","author":"Q Chen","year":"2023","unstructured":"Chen Q, Shao J, Xue T, et al. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer. Eur Radiol. 2023;33(2):947\u201358. https:\/\/doi.org\/10.1007\/s00330-022-09109-3.","journal-title":"Eur Radiol"},{"issue":"1","key":"1869_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1186\/s12967-023-04437-4","volume":"21","author":"W Kang","year":"2023","unstructured":"Kang W, Qiu X, Luo Y, et al. Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis. J Transl Med. 2023;21(1):598. https:\/\/doi.org\/10.1186\/s12967-023-04437-4. Published 2023 Sep 6.","journal-title":"J Transl Med"},{"issue":"1","key":"1869_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12938-023-01190-z","volume":"22","author":"E Trivizakis","year":"2023","unstructured":"Trivizakis E, Koutroumpa NM, Souglakos J, Karantanas A, Zervakis M, Marias K. Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature. Biomed Eng Online. 2023;22(1):125. https:\/\/doi.org\/10.1186\/s12938-023-01190-z. Published 2023 Dec 15.","journal-title":"Biomed Eng Online"},{"key":"1869_CR16","doi-asserted-by":"publisher","first-page":"1287995","DOI":"10.3389\/fonc.2024.1287995","volume":"14","author":"C Zhou","year":"2024","unstructured":"Zhou C, Zhang YF, Guo S, et al. Multimodal data integration for predicting progression risk in castration-resistant prostate cancer using deep learning: a multicenter retrospective study. Front Oncol. 2024;14:1287995. https:\/\/doi.org\/10.3389\/fonc.2024.1287995.","journal-title":"Front Oncol"},{"issue":"2","key":"1869_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00432-023-05574-5","volume":"150","author":"YF Zhang","year":"2024","unstructured":"Zhang YF, Zhou C, Guo S, et al. Deep learning algorithm-based multimodal MRI radiomics and pathomics data improve prediction of bone metastases in primary prostate cancer. J Cancer Res Clin Oncol. 2024;150(2):78. https:\/\/doi.org\/10.1007\/s00432-023-05574-5.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"1869_CR18","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biology Vol. 2006;7(10):R100. https:\/\/doi.org\/10.1186\/gb-2006-7-10-r100.","journal-title":"Genome Biology Vol"},{"issue":"6","key":"1869_CR19","doi-asserted-by":"publisher","first-page":"e0287705","DOI":"10.1371\/journal.pone.0287705","volume":"18","author":"T Nguyen","year":"2023","unstructured":"Nguyen T, Mengersen K, Sous D, Liquet B. SMOTE-CD: SMOTE for compositional data. PLoS ONE. 2023;18(6):e0287705. https:\/\/doi.org\/10.1371\/journal.pone.0287705.","journal-title":"PLoS ONE"},{"issue":"1","key":"1869_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/bimj.200900028","volume":"52","author":"JJ Goeman","year":"2010","unstructured":"Goeman JJ. L1 penalized Estimation in the Cox proportional hazards model. Biom J. 2010;52(1):70\u201384. https:\/\/doi.org\/10.1002\/bimj.200900028.","journal-title":"Biom J"},{"issue":"1","key":"1869_CR21","doi-asserted-by":"publisher","first-page":"22495","DOI":"10.1038\/s41598-021-01900-4","volume":"11","author":"Y Yanai","year":"2021","unstructured":"Yanai Y, Kosaka T, Mikami S, et al. CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer. Sci Rep. 2021;11(1):22495. https:\/\/doi.org\/10.1038\/s41598-021-01900-4.","journal-title":"Sci Rep"},{"issue":"4","key":"1869_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/life13040910","volume":"13","author":"RV Teic\u0103","year":"2023","unstructured":"Teic\u0103 RV, \u0218erb\u0103nescu MS, Florescu LM, Gheonea IA. Tumor area highlighting using T2WI, ADC map, and DWI sequence fusion on BpMRI images for better prostate cancer diagnosis. Life (Basel). 2023;13(4):910. https:\/\/doi.org\/10.3390\/life13040910.","journal-title":"Life (Basel)"},{"issue":"20","key":"1869_CR23","doi-asserted-by":"publisher","first-page":"20251","DOI":"10.1002\/cam4.6526","volume":"12","author":"KS Wagner-Larsen","year":"2023","unstructured":"Wagner-Larsen KS, Hodneland E, Fasmer KE, et al. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer. Cancer Med. 2023;12(20):20251\u201365. https:\/\/doi.org\/10.1002\/cam4.6526.","journal-title":"Cancer Med"},{"issue":"11","key":"1869_CR24","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi C, Chan TA, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42(11):1825\u201363. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.010.","journal-title":"Cancer Cell"},{"issue":"8","key":"1869_CR25","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/0284186X.2019.1598576","volume":"58","author":"Y Sun","year":"2019","unstructured":"Sun Y, Reynolds HM, Wraith D, et al. Automatic stratification of prostate tumour aggressiveness using multiparametric MRI: a horizontal comparison of texture features. Acta Oncol. 2019;58(8):1118\u201326. https:\/\/doi.org\/10.1080\/0284186X.2019.1598576.","journal-title":"Acta Oncol"},{"key":"1869_CR26","doi-asserted-by":"publisher","first-page":"816005","DOI":"10.3389\/fimmu.2022.816005","volume":"13","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zheng Y, Sheng J, et al. CD3\u2009+\u2009CD4-CD8- (Double-Negative) T cells in inflammation, immune disorders and cancer. Front Immunol. 2022;13:816005. https:\/\/doi.org\/10.3389\/fimmu.2022.816005.","journal-title":"Front Immunol"},{"issue":"7","key":"1869_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/mc.23192","volume":"59","author":"CL Ihle","year":"2020","unstructured":"Ihle CL, Owens P. Integrating the immune microenvironment of prostate cancer induced bone disease. Mol Carcinog. 2020;59(7):822\u20139. https:\/\/doi.org\/10.1002\/mc.23192.","journal-title":"Mol Carcinog"},{"issue":"12","key":"1869_CR28","doi-asserted-by":"publisher","first-page":"T179","DOI":"10.1530\/ERC-16-0422","volume":"23","author":"I Coutinho","year":"2016","unstructured":"Coutinho I, Day TK, Tilley WD, Selth LA. Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Endocr Relat Cancer. 2016;23(12):T179\u201397. https:\/\/doi.org\/10.1530\/ERC-16-0422.","journal-title":"Endocr Relat Cancer"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01869-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:02:38Z","timestamp":1755032558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01869-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01869-w","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of the Second Affiliated Hospital of Chongqing Medical University with a waiver of the requirement for patient informed consent (Approval No. [2024]130). The study has been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}